2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features
出版年份 2011 全文链接
标题
2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features
作者
关键词
-
出版物
ARTHRITIS CARE & RESEARCH
Volume 63, Issue 4, Pages 465-482
出版商
Wiley
发表日期
2011-03-31
DOI
10.1002/acr.20460
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
- (2010) J. S. Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis
- (2010) Jennifer M. Grossman et al. ARTHRITIS CARE & RESEARCH
- Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis
- (2009) H. M. Albers et al. ARTHRITIS AND RHEUMATISM
- Development and validation of a composite disease activity score for juvenile idiopathic arthritis
- (2009) Alessandro Consolaro et al. ARTHRITIS AND RHEUMATISM
- Anakinra for Systemic Juvenile Arthritis
- (2009) Andrew Zeft et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Monitoring Methotrexate Toxicity in Juvenile Idiopathic Arthritis
- (2009) L. KOCHARLA et al. JOURNAL OF RHEUMATOLOGY
- Clinical Remission in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Anti-Tumor Necrosis Factor Agents
- (2009) R. A.G. RUSSO et al. JOURNAL OF RHEUMATOLOGY
- Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis
- (2008) P Tynjala et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register
- (2008) F H M Prince et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry
- (2008) G Horneff et al. ANNALS OF THE RHEUMATIC DISEASES
- Optimal treatment of knee monarthritis in juvenile idiopathic arthritis: A decision analysis
- (2008) Timothy Beukelman et al. ARTHRITIS AND RHEUMATISM
- American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
- (2008) Kenneth G. Saag et al. ARTHRITIS AND RHEUMATISM
- The pattern of response to anti–interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis
- (2008) Marco Gattorno et al. ARTHRITIS AND RHEUMATISM
- Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis
- (2008) Silvia Magni-Manzoni et al. ARTHRITIS AND RHEUMATISM
- Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
- (2008) Daniel J. Lovell et al. ARTHRITIS AND RHEUMATISM
- Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study
- (2008) Norman Ilowite et al. CLINICAL RHEUMATOLOGY
- Anti-Cyclic Citrullinated Peptide Antibodies in Patients with Juvenile Idiopathic Arthritis
- (2008) H. M. Habib et al. IMMUNOLOGICAL INVESTIGATIONS
- Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial
- (2008) Nicolino Ruperto et al. LANCET
- Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis
- (2008) Daniel J. Lovell et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started